https://www.einpresswire.com/article/929034320/abl-diagnostics-announces-ultragene-respiratory-pathogens-21-after-ce-ivd-registration-by-abl-sa-luxembourg
Improving Disease Management through Innovative Microbiology Solutions
ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations
https://www.einpresswire.com/article/928571332/abl-diagnostics-selected-by-the-vry-commercial-court-to-acquire-texcell-s-operations
DeepChek® & HybridChek TB Assays & SoftwareComplete Coverage for Tuberculosis Drug Resistance Testing by Amplicon & Hybrid Capture NGS Sequencing.
https://mailchi.mp/abldiagnostics/tb2026?e=e8da2024cf
ABL Diagnostics Confirms BSI Partnership for IVDR Transition and Long-Term Availability of its CE-IVD Medical Devices
https://www.einpresswire.com/article/927085611/abl-diagnostics-confirms-bsi-partnership-for-ivdr-transition-and-long-term-availability-of-its-ce-ivd-medical-devices
